Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies

Clinical trial NCT03739931 · COMPLETED

Trial details

NCT number: NCT03739931
Sponsor: ModernaTX, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Dose Escalation: Relapsed/Refractory Solid Tumor Malignancies or Lymphoma Dose Expansion: Triple Negative Breast Cancer, HNSCC, Non-Hodgkins, Urothelial Cancer, Immune Checkpoint Refractory Melanoma, and NSCLC Lymphoma

Start date: 2018-11-27
Primary completion: 2025-08-01
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.